(Q37254739)

19 August 2017

1 reference

title

Addressing circadian rhythm disturbances in depressed patients (English)

1 reference

19 August 2017

0 references

R W Lam

1

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 September 2008

1 reference

Journal of Psychopharmacology

19 August 2017

published in

1 reference

19 August 2017

volume

22

1 reference

19 August 2017

issue

7 Suppl

1 reference

19 August 2017

page(s)

13-18

1 reference

Successful use of S20098 and melatonin in an animal model of delayed sleep-phase syndrome (DSPS).

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

New selective ligands of human cloned melatonin MT1 and MT2 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Partial remission in depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Depressive relapses and incomplete recovery from index episode

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Placebo-controlled trial of agomelatine in the treatment of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

24-h Monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolactin in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

The influence of baseline severity on efficacy of escitalopram and citalopram in the treatment of major depressive disorder: an extended analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Depression and insomnia: questions of cause and effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Antidepressants and their effect on sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Circadian genes, rhythms and the biology of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Diurnal hypersecretion of growth hormone in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Severe depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

The burden of severe depression: a review of diagnostic challenges and treatment alternatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Place of chronic insomnia in the course of depressive and anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Serotonergic innervation of the hypothalamic suprachiasmatic nucleus and photic regulation of circadian rhythms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Primary insomnia: a risk factor to develop depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Sleep complaints and depression in an aging cohort: A prospective perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Report by the ACNP Task Force on response and remission in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Multiple recurrences of major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Sleep microstructure around sleep onset differentiates major depressive insomnia from primary insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

The link between sleep and depression: the effects of antidepressants on EEG sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Mammalian melatonin receptors: molecular biology and signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

Agomelatine: a preliminary review of a new antidepressant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092591

21 January 2018

Identifiers

DOI

10.1177/0269881108092591

1 reference

19 August 2017

1 reference